Chemical Structure : CDD-3013
货号: PC-27742Not For Human Use, Lab Use Only.
CDD-3013 is a potent and selective inhibitor of c-Jun N-terminal kinase (JNK) with Kd of 0.12/0.72/0.75 nM for JNK1/2/3 respectively, IC50 of 0.15/0.15/0.11 nM in NanoBRET intracellular target engagement assays.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CDD-3013 is a potent and selective inhibitor of c-Jun N-terminal kinase (JNK) with Kd of 0.12/0.72/0.75 nM for JNK1/2/3 respectively, IC50 of 0.15/0.15/0.11 nM in NanoBRET intracellular target engagement assays.
CDD-3013 (0.1-10 uM) induces dose-dependent reductions in IL1β-mediated phosphorylation of Ser73 (pSer73) and pSer63 JUN phosphorylation in L1β-stimulated 12Z peritoneal endometriotic epithelial cells.
CDD-3013 (5 uM) significantly decreases the expression of MMP3 and IL8 in endometriotic 12Z cells treated with IL1β, with no impact on viability up to 130 uM.
CDD-3013 potently inhibits IL1β-induced expression of IL18, TNC, DUSP8, CREB5, and TRAF1, suppresses inflammatory gene expression in primary derived endometriotic stromal cells.
CDD-3013 (10 mg/kg) reduces lesion number and decreases macrophage infiltration and proliferation in an induced mouse model of endometriosis.
| 分子量 | 482.56 | |
| 分子式 | C27H22N4O3S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Madasu C, et al. Proc Natl Acad Sci U S A. 2026 Aug 25;123(34):e2607561123.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright